Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual targeting of DDX3 and eIF4A by the translation inhibitor rocaglamide A
Mingming Chen, Miwako Asanuma, Mari Takahashi, et al.
Cell chemical biology (2020) Vol. 28, Iss. 4, pp. 475-486.e8
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Cellular functions of eukaryotic RNA helicases and their links to human diseases
Katherine E. Bohnsack, Soon Yi, Sarah Venus, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 10, pp. 749-769
Closed Access | Times Cited: 68
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer
Regina Cencic, Young Kyuen Im, Sai Kiran Naineni, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 4
Open Access | Times Cited: 13
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access | Times Cited: 1
The human DEAD-box helicase DDX3X as a regulator of mRNA translation
Cathal S. Ryan, Martina Schröder
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 29
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL
Anne Largeot, Vanessa Klapp, Elodie Viry, et al.
Blood (2023)
Open Access | Times Cited: 19
Natural compounds modulating mitophagy: Implications for cancer therapy
Min Cao, Yancheng Tang, Yufei Luo, et al.
Cancer Letters (2023) Vol. 582, pp. 216590-216590
Closed Access | Times Cited: 18
Calibrated ribosome profiling assesses the dynamics of ribosomal flux on transcripts
Kotaro Tomuro, Mari Mito, Hirotaka Toh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
Na Zhao, Elena B. Kabotyanski, Alexander B. Saltzman, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 24
Open Access | Times Cited: 16
A parasitic fungus employs mutated eIF4A to survive on rocaglate-synthesizing Aglaia plants
Mingming Chen, Naoyoshi Kumakura, Hironori Saito, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 14
Ribosome profiling: a powerful tool in oncological research
Dan Su, Chen Ding, Jiangdong Qiu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells
Sarah Wilmore, Karly‐Rai Rogers‐Broadway, Joe Taylor, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 17-18, pp. 6337-6349
Open Access | Times Cited: 28
Ligand‐Directed Chemistry for Protein Labeling for Affinity‐Based Protein Analysis
Seiji Sakamoto, Itaru Hamachi
Israel Journal of Chemistry (2023) Vol. 63, Iss. 3-4
Closed Access | Times Cited: 12
DMDA-PatA mediates RNA sequence-selective translation repression by anchoring eIF4A and DDX3 to GNG motifs
Hironori Saito, Yuma Handa, Mingming Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates—A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics
Gaspar Taroncher‐Oldenburg, Christin Müller, Wiebke Obermann, et al.
Microorganisms (2021) Vol. 9, Iss. 3, pp. 540-540
Open Access | Times Cited: 27
Enantioselective Intermolecular Mannich-Type Interception of Phenolic Oxonium Ylide for the Direct Assembly of Chiral 2,2-Disubstituted Dihydrobenzofurans
Kemiao Hong, Shanliang Dong, Xinxin Xu, et al.
ACS Catalysis (2021) Vol. 11, Iss. 12, pp. 6750-6756
Closed Access | Times Cited: 24
Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy
Cristina Mir, Yoelsis García-Mayea, Matilde E. Lleonart
Seminars in Cancer Biology (2022) Vol. 86, pp. 69-83
Closed Access | Times Cited: 19
Targeting DEAD‐box RNA helicases: The emergence of molecular staples
Sai Kiran Naineni, Françis Robert, Bhushan Nagar, et al.
Wiley Interdisciplinary Reviews - RNA (2022) Vol. 14, Iss. 2
Closed Access | Times Cited: 18
The DEAD-box helicase eIF4A1/2 acts as RNA chaperone during mitotic exit enabling chromatin decondensation
Ramona Jühlen, Sabine C. Wiesmann, Anja Scheufen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Discovery of RNA-Protein Molecular Clamps Using Proteome-Wide Stability Assays
Stanley I. Goldstein, Alice C. Fan, Zihao Wang, et al.
Journal of Proteome Research (2025)
Closed Access
Potential therapeutic targets of eukaryotic translation initiation factors in tumor therapy
Yujie Zhang, Tianyou Liu, Pengyu Li, et al.
European Journal of Medicinal Chemistry (2025), pp. 117638-117638
Closed Access
Distinct modes of interaction within eIF4F-like complexes and susceptibility to the RocA inhibitor for the Trypanosoma brucei EIF4AI translation initiation factor
Danielle Maria Nascimento Moura, A. Soares, ⁠Ana Beatriz dos Santos Silva, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322812-e0322812
Open Access
Advances in ribosome profiling technologies
Kotaro Tomuro, Shintaro Iwasaki
Biochemical Society Transactions (2025)
Open Access
Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae)
Harald Greger
Phytochemistry Reviews (2021) Vol. 21, Iss. 3, pp. 725-764
Open Access | Times Cited: 23
Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome
J.J. David Ho, Tyler A. Cunningham, Paola Manara, et al.
Cell Reports (2021) Vol. 37, Iss. 2, pp. 109806-109806
Open Access | Times Cited: 22
Reanalysis of ribosome profiling datasets reveals a function of rocaglamide A in perturbing the dynamics of translation elongation via eIF4A
Fajin Li, Jianhuo Fang, Yifan Yu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top